HLUN-A:CPH
H Lundbeck A/S Class A
DKKÂ 45,05
arrow_upward
+0,33%(+0,15) 1D
16 Okt., 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUN-A...
Open
DKKÂ 45,00
High
DKKÂ 45,60
Low
DKKÂ 44,90
Mkt. cap
47,02Â mjd
Avg. vol.
100,68Â k
Volume
0,00
52-wk high
DKKÂ 45,60
52-wk low
DKKÂ 31,40
Shares outstanding
199,15Â m
No. of employees
5Â k
Open
DKKÂ 45,00
High
DKKÂ 45,60
Low
DKKÂ 44,90
Mkt. cap
47,02Â mjd
Avg. vol.
100,68Â k
Volume
0,00
52-wk high
DKKÂ 45,60
52-wk low
DKKÂ 31,40
Shares outstanding
199,15Â m
No. of employees
5Â k
News stories
From web sources and news partners
Simply Wall Street
·
36 minute gelede
Marqeta (MQ), What Is Behind The Latest Attention?
Detroit Free Press
·
1 uur gelede
Memory-chip rout, inflation, CoreWeave: The week on Wall Street
Yahoo Finance
·
1 uur gelede
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
MarketWatch
·
14 uur gelede
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5Â k
Founded1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com